114 related articles for article (PubMed ID: 6333665)
1. Determination and characterization of immunoreactive trypsin in amniotic fluid from normal and cystic fibrosis fetuses.
Borgström A; Sveger T; Kullander S; Svanberg L; Hösli P
Pediatr Res; 1984 Oct; 18(10):957-9. PubMed ID: 6333665
[TBL] [Abstract][Full Text] [Related]
2. Levels and molecular forms of immunoreactive trypsin and chymotrypsin in amniotic fluids from normal and cystic fibrosis fetus: evidence for a lack of activation of proteolytic zymogens in cystic fibrosis fetus.
Carrère J; Muller F; Boué A; Guy-Crotte O; Figarella C
J Pediatr Gastroenterol Nutr; 1992 Feb; 14(2):198-203. PubMed ID: 1593375
[TBL] [Abstract][Full Text] [Related]
3. Amniotic immunoreactive trypsin in pregnancies with normal and pathological outcomes.
Laroche D; Herlicoviez M; Pasquet C; Travert G; Fernandez Y
Acta Obstet Gynecol Scand; 1987; 66(7):587-90. PubMed ID: 3439439
[TBL] [Abstract][Full Text] [Related]
4. Behaviour of serum immunoreactive trypsin after serum activation by enterokinase in normal and cystic fibrosis patients. Evidence of a trypsin-alpha 1-proteinase inhibitor complex in some cystic fibrosis patients.
Carrère J; Chazalette JP; Figarella C
Biochim Biophys Acta; 1989 Dec; 993(2-3):137-42. PubMed ID: 2480820
[TBL] [Abstract][Full Text] [Related]
5. Protease inhibitor and defective proteolysis in cystic fibrosis.
Hsieh MC; Berry HK
Dig Dis Sci; 1988 Mar; 33(3):282-8. PubMed ID: 2449319
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactive trypsin and the prenatal diagnosis of cystic fibrosis.
Brock DJ; Hayward C; Gosden C; Rodeck C
Br J Obstet Gynaecol; 1984 May; 91(5):449-52. PubMed ID: 6722064
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of murine monoclonal antibodies against immunoreactive trypsinogen for newborn screening of cystic fibrosis.
Morejón García G; García de la Rosa I; Feal Carballo S; Castells Martínez EM; Stable Vernier IC; Quintana Guerra JM; Hernández Pérez L; Lafita Delfino Y; Pérez Morás PL; Pupo Infante M; Figueredo Lago JE; González Reyes EC
Anal Biochem; 2020 Feb; 591():113569. PubMed ID: 31887264
[TBL] [Abstract][Full Text] [Related]
8. Neonatal screening for cystic fibrosis, using immunoreactive trypsin assay in dried blood spots.
Crossley JR; Smith PA; Edgar BW; Gluckman PD; Elliott RB
Clin Chim Acta; 1981 Jun; 113(2):111-21. PubMed ID: 7249357
[TBL] [Abstract][Full Text] [Related]
9. Amniotic fluid disaccharidases in the prenatal detection of cystic fibrosis.
Kleijer WJ; Janse HC; van Diggelen OP; Niermeijer MF
Prenat Diagn; 1985; 5(2):135-43. PubMed ID: 3991466
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactive trypsin level in fetoscopically-obtained cord sera of second trimester fetuses.
Ryley HC; Rodeck CH
Prenat Diagn; 1984; 4(4):303-6. PubMed ID: 6483790
[TBL] [Abstract][Full Text] [Related]
11. Origin and levels of trypsin in amniotic fluid throughout pregnancy.
Pocknee RC; Abramovich DR
Br J Obstet Gynaecol; 1982 Feb; 89(2):142-4. PubMed ID: 7066247
[TBL] [Abstract][Full Text] [Related]
12. Microvillar enzyme analysis in amniotic fluid and the prenatal diagnosis of cystic fibrosis.
Aitken DA; Yaqoob M; Ferguson-Smith MA
Prenat Diagn; 1985; 5(2):119-27. PubMed ID: 2859584
[TBL] [Abstract][Full Text] [Related]
13. [Activity of enzymes in amniotic fluid in prenatal diagnosis of cystic fibrosis].
Gorbunova VN; Romanenko OP; Vakharlovskiĭ VG; Pigina TV; Kalashnikova EP; Moiseenko MM; El'gart IIa; Baranov VS
Genetika; 1989 Sep; 25(9):1664-72. PubMed ID: 2574699
[TBL] [Abstract][Full Text] [Related]
14. [Prenatal diagnosis of mucoviscidosis: biochemical technics and studies of affected fetuses].
Muller F; Boué C
Chir Pediatr; 1986; 27(4):220-3. PubMed ID: 2880676
[TBL] [Abstract][Full Text] [Related]
15. Disaccharidase deficiency in amniotic fluid from cases of cystic fibrosis.
Schwartz M; Brandt NJ
Prenat Diagn; 1985; 5(2):145-8. PubMed ID: 2859586
[TBL] [Abstract][Full Text] [Related]
16. [Screening of newborn infants for cystic fibrosis. A combined analysis of immunoreactive trypsin and delta F508 mutation--a screening without false positive results].
Nørgaard-Pedersen B; Høgdall EV; Arends J; Vuust J
Ugeskr Laeger; 1994 Jun; 156(25):3757-60. PubMed ID: 8059453
[TBL] [Abstract][Full Text] [Related]
17. Development of a screening system for cystic fibrosis: meconium or blood spot trypsin assay or both?
Pederzini F; Faraguna D; Giglio L; Pedrotti D; Perobelli L; Mastella G
Acta Paediatr Scand; 1990 Oct; 79(10):935-42. PubMed ID: 2124772
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test.
Rock MJ; Mischler EH; Farrell PM; Bruns WT; Hassemer DJ; Laessig RH
Pediatr Pulmonol; 1989; 6(1):42-8. PubMed ID: 2704582
[TBL] [Abstract][Full Text] [Related]
19. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
Corbetta C; Seia M; Bassotti A; Ambrosioni A; Giunta A; Padoan R
J Med Screen; 2002; 9(2):60-3. PubMed ID: 12133923
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations.
Hammond KB; Abman SH; Sokol RJ; Accurso FJ
N Engl J Med; 1991 Sep; 325(11):769-74. PubMed ID: 1870650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
